Platelet activation: A link between psoriasis per se and subclinical atherosclerosis - A case-control study

British Journal of Dermatology

Volumn 169, Issue 1, 2013, Pages 68-75

  Saleh, H M A ^a   Attia, E A S ^a   Onsy, A M ^a   Saad, A A ^b   Abd Ellah, M M M ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

L SELECTIN; PADGEM PROTEIN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME; TRANSTHORACIC ECHOCARDIOGRAPHY; ULTRASOUND SCANNER; ANALYSIS OF VARIANCE; BLOOD; ECHOCARDIOGRAPHY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASODILATATION; YOUNG ADULT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PSORIASIS; VASODILATION; YOUNG ADULT;

EID: 84879953497     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12285     Document Type: Article

References (52)

1. Griffiths CE, Barker JN,. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-71.
2. Icen M, Crowson CS, McEvoy MT, et al,. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol 2009; 60: 394-401.
3. Packard RR, Libby P,. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008; 54: 24-38.
4. Abou-Raya A, Abou-Raya S,. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 2006; 5: 331-7.
5. Wakkee M, Thio HB, Prens EP, et al,. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007; 190: 1-9.
6. Tamagawa-Mineoka R, Katoh N, Kishimoto S,. Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin. J Am Acad Dermatol 2009; 62: 621-6.
7. Jenning LK,. Role of platelets in atherothrombosis. Am J Cardiol 2009; 103 (Suppl. 3): 4A-10A.
8. Fisher M, Levine HP, Albert L, et al,. Marker proteins of platelet activation in patients with cerebrovascular disease. Arch Neurol 1982; 39: 692-5.
9. Slavka G, Perkmann T, Haslacher H, et al,. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol 2011; 31: 1215-18.
10. Shattil SJ, Cunnigham M, Hoxie JA,. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307-15.
11. Jurate G, Diehl S, Varwig D, et al,. Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis. Exp Dermatol 2010; 19: 736-41.
12. Wagner DD, Burger PC,. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003; 23: 2131-7.
13. Chen M, Geng J,. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp (Warsz) 2006; 54: 75-84.
14. Deanfield J, Donald A, Ferri C, et al,. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds. J Hypertens 2005; 23: 7-17.
15. Chan SY, Mancini GB, Kuramoto L, et al,. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003; 42: 1037-43.
16. Mallbris L, Akre O, Granath F, et al,. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004; 19: 225-30.
17. Neimann AL, Shin DB, Wang X, et al,. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-35.
18. Gisondi P, Tessari G, Conti A, et al,. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73.
19. Jin Y, Zhang F, Yang S, et al,. Combined effects of HLA-Cw6, body mass index and waist-hip ratio on psoriasis vulgaris in Chinese Han population. J Dermatol Sci 2008; 52: 123-9.
20. Jellinger C, Paul S,. What you need to know about prediabetes. Am Coll Endocrinol 2009; 1: 52-63. Available at: http://www.powerofprevention.com (last accessed 24 March 2013).
21. Sheridan MJ, Cooper JN, Erario M, Cheifetz CE,. Pistachio nut consumption and serum lipid levels. J Am Coll Nutr 2007; 26: 141-8.
22. Carretero OA, Oparil S,. Essential hypertension Part I: definition and etiology. Circulation 2000; 101: 329-35.
23. Bhor U, Pande S,. Scoring systems in dermatology. Indian J Dermatol Venereol Leprol 2006; 72: 315-21.
24. Schäfer I, Hacker J, Rustenbach SJ, et al,. Concordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatment. Eur J Dermatol 2010; 20: 62-7.
25. Mrowietz U, Kragballe K, Reich K, et al,. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011; 303: 1-10.
26. Canpolat F, Akpinar H, Eskioǧlu F,. Mean platelet volume in psoriasis and psoriatic arthritis. Clin Rheumatol 2010; 29: 325-8.
27. Brunner H, Cockcroft JR, Deanfield J, et al,. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23: 233-46.
28. Vignon P, Mentec H, Terré S, et al,. Diagnostic accuracy and therapeutic impact of transthoracic and transesophageal echocardiography in mechanically ventilated patients in the ICU. Chest 1994; 106: 1829-34.
29. Joseph MX, Disney PJS, Da Costa R, Hutchison SJ,. Transthoracic echocardiography to identify or exclude cardiac cause of shock. Chest 2004; 126: 1592-7.
30. Ludwig RJ, Schultz JE, Boehncke WH, et al,. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 2004; 122: 830-6.
31. Pelletier F, Garnache-Ottou F, Angelot F, et al,. Increased levels of circulating endothelial-derived microparticles and small-size platelet-derived microparticles in psoriasis. J Invest Dermatol 2011; 131: 1573-6.
32. Koyama H, Maeno T, Fukumoto S, et al,. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 2003; 108: 524-9.
33. Weber C,. Platelets and chemokines in atherosclerosis: partners in crime. Circ Res 2005; 96: 612-16.
34. Agmon Y, Khandheria BK, Meissner I, et al,. Is aortic dilatation an atherosclerosis-related process? Clinical, laboratory, and transesophageal echocardiographic correlates of thoracic aortic dimensions in the population with implications for thoracic aortic aneurysm formation. J Am Coll Cardiol 2003; 42: 1076-83.
35. Jiang JJ, Chen XF, Liu XM, et al,. Aortic root dilatation is associated with carotid intima-media thickness but not with carotid plaque in hypertensive men. Acta Cardiol 2009; 64: 645-51.
36. Mann DL, Bristow MR,. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005; 111: 2837-49.
37. Biyik I, Narin A, Bozok MA, Ergene O,. Echocardiographic and clinical abnormalities in patients with psoriasis. J Int Med Res 2006; 34: 632-9.
38. Karadag AS, Yavuz B, Ertugrul DT, et al,. Is psoriasis a pre-atherosclerotic disease? Increased insulin resistance and impaired endothelial function in patients with psoriasis. Int J Dermatol 2010; 49: 642-6.
39. Karabudak O, Ulusoy RE, Erikci AA, et al,. Inflammation and hypercoagulable state in adult psoriatic men. Acta Derm Venereol 2008; 88: 337-40.
40. Beyan C, Kaptan K, Ifran A,. Platelet count, mean platelet volume, platelet distribution width, and plateletcrit do not correlate with optical platelet aggregation responses in healthy volunteers. J Thromb Thrombolysis 2006; 22: 161-4.
41. Hashimoto M, Akishita M, Eto M, et al,. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995; 92: 3431-5.
42. Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA,. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007; 57: 287-93.
43. Balci DD, Balci A, Karazincir S, et al,. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol 2009; 23: 1-6.
44. Gisondi P, Fantin F, Del Giglio M, et al,. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology 2009; 218: 110-13.
45. Ulusoy RE, Karabudak O, Yokusoglu M, et al,. Noninvasive assessment of impaired endothelial function in psoriasis. Rheumatol Int 2010; 30: 479-83.
46. Jensen PR, Zachariae C, Hansen P, Skov L,. Normal endothelial function in patients with mild-to-moderate psoriasis: a case-control study. Acta Derm Venereol 2011; 91: 516-20.
47. Tekin NS, Ilter N, Sancak B, et al,. Nitric oxide levels in patients with psoriasis treated with methotrexate. Mediators Inflamm 2006; 2006: 16043.
48. Hansson GK, Libby P,. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6: 508-19.
49. Yudkin JS,. Insulin resistance and the metabolic syndrome-or the pitfalls of epidemiology. Diabetologia 2007; 50: 1576-86.
50. Leong TT, Fearon U, Veale DJ,. Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis. Curr Rheumatol Rep 2005; 7: 325-9.
51. Rogers MS, D'Amato RJ,. The effect of genetic diversity on angiogenesis. Exp Cell Res 2006; 312: 561-74.
52. Shapiro J, Cohen AD, David M, et al,. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007; 56: 629-34.